Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lloyd-Lavery

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The British Journal of Dermatology|October 16, 2018
Long-term safety data for tofacitinib, an oral Janus kinase inhibitor, for the treatment for psoriasisA Lloyd-Lavery
The British Journal of Dermatology|May 11, 2019
Resolution of severe oral mucosal changes related to vemurafenib therapy with intensive periodontal treatmentM K Shephard, A Lloyd-Lavery
Clinical and Experimental Dermatology|February 4, 2012
'Once seen, never forgotten'A Lloyd-Lavery, O Espinosa, R Asher, et al.
Clinical and Experimental Dermatology|March 28, 2013
Awareness of and attitudes towards skin-cancer prevention: a survey of patients in the UK presenting to their general practiceD P Butler, A Lloyd-Lavery, C M G Archer, et al.
International Archives of Allergy and Immunology|October 27, 2010
Common filaggrin null alleles are not associated with hymenoptera venom allergy in EuropeansA Aslam, A Lloyd-Lavery, D A Warrell, et al.
Clinical and Experimental Dermatology|May 29, 2018
What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 2: prevention and treatmentA Lloyd-Lavery, N K Rogers, E Davies, et al.
Clinical and Experimental Dermatology|January 10, 2018
What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 1: epidemiology and methodologyE Davies, N K Rogers, A Lloyd-Lavery, et al.
Clinical and Experimental Dermatology|November 22, 2016
What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 2. Treatment and preventionA Lloyd-Lavery, N K Rogers, S J Hatfield, et al.
Clinical and Experimental Dermatology|November 3, 2016
What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 1. Epidemiology, risk factors and outcomesS J Hatfield, N K Rogers, A Lloyd-Lavery, et al.
Clinical and Experimental Dermatology|February 2, 2019
What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessmentA Lloyd-Lavery, L Solman, D J C Grindlay, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The British Journal of Dermatology|October 16, 2018
Long-term safety data for tofacitinib, an oral Janus kinase inhibitor, for the treatment for psoriasisA Lloyd-Lavery
The British Journal of Dermatology|May 11, 2019
Resolution of severe oral mucosal changes related to vemurafenib therapy with intensive periodontal treatmentM K Shephard, A Lloyd-Lavery
Clinical and Experimental Dermatology|February 4, 2012
'Once seen, never forgotten'A Lloyd-Lavery, O Espinosa, R Asher, et al.
Clinical and Experimental Dermatology|March 28, 2013
Awareness of and attitudes towards skin-cancer prevention: a survey of patients in the UK presenting to their general practiceD P Butler, A Lloyd-Lavery, C M G Archer, et al.
International Archives of Allergy and Immunology|October 27, 2010
Common filaggrin null alleles are not associated with hymenoptera venom allergy in EuropeansA Aslam, A Lloyd-Lavery, D A Warrell, et al.
Clinical and Experimental Dermatology|May 29, 2018
What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 2: prevention and treatmentA Lloyd-Lavery, N K Rogers, E Davies, et al.
Clinical and Experimental Dermatology|January 10, 2018
What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 1: epidemiology and methodologyE Davies, N K Rogers, A Lloyd-Lavery, et al.
Clinical and Experimental Dermatology|November 22, 2016
What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 2. Treatment and preventionA Lloyd-Lavery, N K Rogers, S J Hatfield, et al.
Clinical and Experimental Dermatology|November 3, 2016
What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 1. Epidemiology, risk factors and outcomesS J Hatfield, N K Rogers, A Lloyd-Lavery, et al.
Clinical and Experimental Dermatology|February 2, 2019
What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessmentA Lloyd-Lavery, L Solman, D J C Grindlay, et al.
Pageof 2